These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 6480257)

  • 1. Correlation between the behavior of magnetic iron oxide particles in the lungs of rabbits and phagocytosis.
    Brain JD; Bloom SB; Valberg PA; Gehr P
    Exp Lung Res; 1984; 6(2):115-31. PubMed ID: 6745211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of 99mTc-labeled iron oxide aerosols for human lung deposition and clearance studies.
    Wales KA; Petrow H; Yeates DB
    Int J Appl Radiat Isot; 1980 Nov; 31(11):689-94. PubMed ID: 7450907
    [No Abstract]   [Full Text] [Related]  

  • 3. Ferromagnetic embolization. Experimental evaluation.
    Barry JW; Bookstein JJ; Alksne JF
    Radiology; 1981 Feb; 138(2):341-9. PubMed ID: 7455113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc complexes of ethylenediaminetetraacetic and ethylenediaminetetraacetohydroxamic acids; labelling and biodistribution.
    Láznícková A; Karlícek R; Kvĕtina J; Kronrád L; Kusák V
    Int J Nucl Med Biol; 1984; 11(2):170-4. PubMed ID: 6434462
    [No Abstract]   [Full Text] [Related]  

  • 5. A radiopharmaceutical for the study of the liver: 99mTc-DTPA-asialo-orosomucoid. I: Radiochemical and animal distribution studies.
    Galli G; Maini CL; Orlando P; Deleide G; Valle G
    J Nucl Med Allied Sci; 1988; 32(2):110-6. PubMed ID: 3049961
    [No Abstract]   [Full Text] [Related]  

  • 6. The labelling of magnetically responsive particles with 99mTc and 32P.
    Lichtenstein M; Pojer PM; Spokas RJ
    Int J Nucl Med Biol; 1984; 11(2):153-8. PubMed ID: 6480257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil labeling: problems and pitfalls.
    Thakur ML; Seifert CL; Madsen MT; McKenney SM; Desai AG; Park CH
    Semin Nucl Med; 1984 Apr; 14(2):107-17. PubMed ID: 6427928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current use and future potential of organometallic radiopharmaceuticals.
    Schibli R; Schubiger PA
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1529-42. PubMed ID: 12397472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor imaging with 99mTc-labelled antibody fragments.
    Rhodes BA
    Radioisotopes; 1984 Apr; 33(4):230-6. PubMed ID: 6382454
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides.
    Decristoforo C; Mather SJ
    Q J Nucl Med; 2002 Sep; 46(3):195-205. PubMed ID: 12134136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methods of leukocyte radionuclide labeling and the potentials for using labelled leukocytes in medicine].
    Vorob'eva EN
    Med Radiol (Mosk); 1981 Nov; 26(11):81-6. PubMed ID: 7033713
    [No Abstract]   [Full Text] [Related]  

  • 12. Magnetic responsive cell-based strategies for diagnostics and therapeutics.
    Gonçalves AI; Miranda MS; Rodrigues MT; Reis RL; Gomes ME
    Biomed Mater; 2018 Aug; 13(5):054001. PubMed ID: 29794324
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.